Orforglipron enantiomer

SL-11864

Orforglipron enantiomer, >98%

IUPAC Name : 3-((1R,2R)-1-(5-((R)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((R)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an enantiomer of Orforglipron, which is a novel non-peptidyl oral glucagon-like peptide-1 (GLP-1) receptor agonist, developming for treatment of type 2 diabetes mellitus (T2DM).

References : Cong Z. et al.: Nat Commun., 12(1), 3763, 2021; Choe H. J. et al.: Endocrinol Metab (Seoul) 36(1), 22-29, 2021; Kawai T. et al.: Proc Natl Acad Sci U S A. 17(47), 29959-29967, 2020.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.